Just 26% of Wall Street Analysts Rate Nike a Buy. Is It Time to Be Greedy While Others are Fearful?
Key PointsNike has struggled to show improvements in its sales around the world, especially in China.
Nasdaq News
Belgian Minister To Closely Monitor GSK Restructuring Plan
(RTTNews) - On October 14, The Belgian government has pledged to closely monitor the restructuring plans announced by GSK plc. (GSK), with David Clarinval, Belgium's Deputy Prime Minister and Minister of Employment, emphasizing that the company must comply with all legal obligati
Cameco Stock Is Down 36% From Its All-Time High. Here's What Needs to Happen to Make It a Buy
Key PointsShares of the uranium producer are down despite strong uranium prices and positive sector trends.
ASML Can't Keep Up With 2027 or 2028 Demand. Is It the Best AI Stock to Buy Now?
Key PointsASML plans to increase manufacturing capacity beyond its prior 30% target.
FDA Approves New Self-Injection Option For UCB's ZILBRYSQ In Generalized Myasthenia Gravis
(RTTNews) - UCB (UCBJY) announced that the U.S. FDA has approved a self-administered autoinjector option for ZILBRYSQ (zilucoplan) for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
Quantum Computing Is Still Years Away. These 6 Stocks Show Who Is Closest to Real Revenue.
Key PointsIBM is effectively funding its $10 billion, five‑year quantum push from its mainframe and software cash flows.
JP Morgan Upgrades Brighthouse Financial, Inc. - Preferred Stock to Neutral from Underweight
Fintel reports that on October 15, 2026, JP Morgan upgraded their outlook for Brighthouse Financial, Inc. - Preferred Stock (NASDAQGS:BHFAO) from Underweight to Neutral. Brighthouse Financial, Inc., based in the United States, operates primarily in the insurance industry, focusin
Stocks Settle Mixed as Broader Market Recovers from Chip Stock Rout
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.33% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. December E-mini S&P futures (ESZ26 ) rose +0.28%, and December E-mini...
These 'First Tier' AI Plays Are Back on Sale, Paying Up to 10.8%
For a while, utilities were that sneaky play on AI. A picks-and-shovels provider, if you will.
This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term
Key PointsThe S&P 500 Growth index exclusively holds 151 of the best-performing growth stocks from the regular S&P 500.
Azitra To Implement 1-for-10 Reverse Stock Split
(RTTNews) - Friday, Azitra, Inc. (AZTR) announced plans to implement a 1-for-10 reverse stock split, effective October 26, 2026. The company's shares will continue trading under the AZTR ticker on a split-adjusted basis.
Why Cipher Digital Stock Plunged 26% This Week
Key PointsCipher Digital shares fell 25.7% this week following an $850 million convertible debt offering.
Stocks Settle Mixed as Broader Market Recovers from Chip Stock Rout
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.33% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. December E-mini S&P futures (ESZ26 ) rose +0.28%, and December E-mini...
What the Latest Fed Decision Means for Costco, Walmart, Target, and Home Depot
Key PointsInflation sits at 3.7% according to September’s CPI, and more Fed rate hikes seem likely in 2026 and possibly into 2027.
Neurocrine Presents Real-World Data Mapping Evolving Impact Of Congenital Adrenal Hyperplasia
(RTTNews) - Neurocrine Biosciences (NBIX) reported real-world data demonstrating how the clinical and day-to-day impact of classic congenital adrenal hyperplasia can vary among individuals and evolve throughout a patient's life. Patient records showed growth and bone-age monitori
Fidelity Asian FY26 Net Return Before Tax Falls, Lifts Dividend; Shares Down
(RTTNews) - Fidelity Asian Values PLC (FAS.L), on Friday reported lower net return before tax for fiscal 2026, mainly due to losses in derivative returns, compared to a gain in the previous year. Further, the firm raised final dividend.
CHMP Backs Less Frequent Regeneron's Libtayo Dosing Across Approved Cancer Indications In Europe
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending an updated dosing regimen for Libtayo (cemiplimab) across all approved indicat
Dario Amodei's Anthropic Disclosed That One of Its AI Models Submitted a False Tip in an Unsolved Murder Case -- Police Weren't Notified About It Until Two Months Later. Here's Why That Timeline Could Complicate the Company's IPO.
Key PointsAn AI agent submitting a fake tip about an unsolved murder is a bad look, even for a popular AI company like Anthropic.
The Defense ETF Duel: Old Guard Aerospace or Next-Gen Tech?
Key PointsInvesco Aerospace & Defense ETF has a much larger assets under management (AUM) and a slightly lower expense ratio than First Trust Indxx Aerospace & Defense ETF.
B of A Securities Upgrades Fox to Buy from Underperform
Fintel reports that on October 16, 2026, B of A Securities upgraded their outlook for Fox (NASDAQGS:FOX) (BIT:1FOX) from Underperform to Buy.This rating action follows a prior action by B of A Securities on February 25, 2026, when the firm downgraded the company from Buy to Under
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed